Woebot est évalué comme Chatbot thérapeutique IA. Cette page reprend la structure de l'avis anglais et présente les mêmes critères éditoriaux dans une version localisée.
Dans notre analyse, l'usage le plus pertinent est : Psychiatrists and health systems looking for a patient-facing digital therapeutic to extend CBT-based support between appointments. Particularly relevant for adolescent depression, access-limité populations, and bridging the psychiatric workforce shortage.
Le principal point fort est woebot earns a Good rating in psychiatry as a patient-facing digital therapeutic rather than a clinician tool. Its Stanford-developed CBT approach and FDA Breakthrough Device Designation are notable, though the narrow therapeutic scope limits broader clinical utility. La limite à surveiller est patient-facing tool, not a clinical decision support platform for psychiatrists